Related Experiment Videos
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers
1Harvard Medical School, Boston, Massachusetts, USA.
Cancer
|November 15, 1995
Summary
This study developed a new ovarian cancer screening test using longitudinal CA125II marker levels. The test demonstrated high specificity and improved positive predictive value compared to single assays.
Area of Science:
- Gynecology
- Oncology
- Biomarker Research
Background:
- Ovarian cancer screening remains a challenge due to low sensitivity and specificity of current methods.
- Longitudinal monitoring of tumor markers like CA125II may offer improved early detection capabilities.
Purpose of the Study:
- To develop and validate a novel screening test for ovarian cancer using longitudinal CA125II levels.
- To assess the performance of the developed test in terms of specificity and positive predictive value.
Main Methods:
- Reassayed stored samples for CA125II in postmenopausal women.
- Developed a screening test using linear regression of log(CA125II) on time, analyzing slope and intercept.
- Utilized Bayes' theorem to calculate risk of ovarian cancer (ROC), accounting for assay variability.
Main Results:
- The developed screening test achieved a specificity of 99.8% on the validation set.
- The ROC algorithm identified 83% of ovarian cancers detected within a year.
- The estimated positive predictive value was 16%, significantly higher than single-assay methods.
Conclusions:
- A screening test based on longitudinal CA125II levels and assay variability shows promise for improved ovarian cancer detection.
- The developed ROC algorithm offers a substantial increase in positive predictive value compared to traditional single-point assays.
- Further studies are warranted to confirm the sensitivity of this longitudinal approach.